Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus.

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Abstract Text:

Philip Chung,Patrick J McNamara,Jeffrey J Campion,Martin E Evans,

Pharmacodynamic modeling from earlier experiments in which two ciprofloxacin-susceptible Staphylococcus aureus strains and their corresponding resistant grlA mutants were exposed to a series of ciprofloxacin (J. J. Campion, P. J. McNamara, and M. E. Evans, Antimicrob. Agents Chemother. 49:209-219, 2005) and levofloxacin (J. J. Campion et al., Antimicrob. Agents Chemother. 49:2189-2199, 2005) pharmacokinetic profiles in an in vitro system indicated that the subpopulation-specific estimated maximal killing rate constants were similar for both agents, suggesting a common mechanism of action. We propose two novel pharmacodynamic models that assign mechanisms of action to fluoroquinolones (growth inhibition or death stimulation) and compare the abilities of these models and two other maximum effect models (net effect and MIC based) to describe and predict the changes in the population dynamics observed during our previous in vitro system experiments with ciprofloxacin. A high correlation between predicted and observed viable counts was observed for all models, but the best fits, as assessed by diagnostic tests, and the most precise parameter estimates were obtained with the growth inhibition and net effect models. All models, except the death stimulation model, correctly predicted that resistant subpopulations would not emerge when a high-density culture was exposed to a high initial concentration designed to rapidly eradicate low-level-resistant grlA mutants. Additional experiments are necessary to elucidate which of the proposed mechanistic models best characterizes the antibacterial effects of fluoroquinolone antimicrobial agents.

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Publishing Authors By Initials

P Chung,PJ McNamara,JJ Campion,ME Evans,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Antimicrobial agents and chemotherapy

VOLUME: 50

Page Numbers: 2957-65

Journal Abbreviation:

ISSN: 0066-4804

DAY: 3

MONTH: Sep

YEAR: 2006

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 315061

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus.

AFFILIATION: Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY 40502, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Antimicrob Agents Chemother

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus Related Publications

• A national needs assessment of nurses providing health care to adolescents.
• Application of pharmacological principles to benzodiazepine therapy.
• Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation.
• Black-white differences in health-related quality of life among older adults.
• Cannabinoids: the separation of central from peripheral effects on a structural basis.
• Chiropractic clinical research: progress and recommendations.
• Determinants of cockroach and mouse exposure and associations with asthma in families and elderly individuals living in New York City public housing.
• Distinguishing product and practice regulation in personalized medicine.
• Duplex strand joining reactions catalyzed by vaccinia virus DNA polymerase.
• Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters.
• Embryo production from superovulated sheep inseminated with sex-sorted ram spermatozoa.
• Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.
• Homocysteine in health and disease.
• Is lower cognitive function in one spouse associated with depressive symptoms in the other spouse?
• Judith corker, 1967-1998.
• Maintenance of delay of gratification by four chimpanzees (Pan troglodytes): the effects of delayed reward visibility, experimenter presence, and extended delay intervals.
• Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus.
• Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.
• Prodigious alcohol consumption by Australian rugby league footballers.
• Relative weight and mobility: a longitudinal study in a biracial population of older adults.
• STAT5 acts as a repressor to regulate early embryonic erythropoiesis.
• Serum estradiol-17beta concentrations during spontaneous silent estrus and after prostaglandin treatment in the mare.
• Smad1 expands the hemangioblast population within a limited developmental window.
• Strategies for treatment-resistant depression.
• Strategies for treatment-resistant depression.
• The acute effects of gabapentin in combination with alcohol in heavy drinkers.
• The effects of xylazine and alpha-adrenoreceptor antagonists on bovine uterine contractility in vitro.
• The evaluation of extracorporeal shock wave therapy on collagenase induced superficial digital flexor tendonitis.
• To the editor.
• Treatment approaches for interstitial cystitis: multimodality therapy.